Genesis MedTech has secured approval from China’s National Medical Products Administration for the launch of the laparoscopic surgical device, ArtiSential, in the country.
South Korean medical device company LivsMed developed the ArtiSential device and in 2021, Genesis MedTech entered an exclusive distribution agreement with LivsMed to launch this device into the Chinese market.
Go deeper with GlobalData
The device mimics the surgeon’s wrist and finger movements, offering several clinical advantages that improve surgical precision and outcomes.
For enabling full access to narrow surgical sites, the double-joint end-effector of the device facilitates freedom of movement.
Designed to operate on a fully mechanical structure with tactile feedback conduction, the device provides a realistic feel of the endoscopic operation to the surgeon.
Furthermore, it offers a full range of customised end-effectors and can meet several clinical needs.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataArtiSential was launched in Korea in 2018 and in the US market the following year.
The device is already marketed in various countries, including the UK, Germany, Australia and Japan.
With the launch of ArtiSential, surgeons in China will be equipped with an instrument to provide better care to their patients.
Headquartered in Singapore, Genesis MedTech supplies multi-therapy medical device products in emerging markets.
Created by Dr Jung Joo Lee, LivsMed focuses on transforming the capabilities of minimally invasive surgery and improving surgical outcomes.
